Cambridge, Mass.-based startup Trinetx Inc. has raised a $40 million series D to better match patients with clinical trials and real-world evidence efforts. Merck Global Health Innovation Fund, the $500 million digital-health focused strategic fund of Merck & Co. Inc., led the financing. It boosted the total raised by the company to more than $102 million. New investors Mitsui & Co., Itochu Technology Ventures, Itochu Corp. and existing investors MPM Capital, F2 Ventures and Deerfield Management also participated in the latest round.